# Schmitt Daniel M: insider transactions

SEC CIK 1318470. Roles and transactions as reported on Form 4. Latest Form 4 filed 2026-10-29.

## Roles

| Company | Role | Transactions | First | Latest |
| --- | --- | ---: | --- | --- |
| [Actuate Therapeutics, Inc.](/companies/actu.md) | President, CEO and Director, Director, Officer | 2 | 2026-10-28 | 2026-10-28 |

## Transactions: 2

Every transaction reported, newest first. Codes P and S are open-market purchases and sales. Reported price is as stated on the form.

| Date | Company | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-28 | [Actuate Therapeutics, Inc.](/companies/actu.md) | Purchase (P), derivative | 70,422 | $0.00 | $0 | [Form 4](/filings/0001683168-26-008147.md) |
| 2026-10-28 | [Actuate Therapeutics, Inc.](/companies/actu.md) | Purchase (P) | 140,844 | $0.355 | $50.0k | [Form 4](/filings/0001683168-26-008147.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Nov 1, 2026, 07:31 ET. No prices; not investment advice.